CHI3L1 and inflammatory bowel disease: Consequently, in vivo neutralization of CHI3L1 using an anti-CHI3L1 antibody decreased the severity of IL-13-dominant airway inflammation during RSV infection.154 In IBD CHI3L1 enhances bacterial adhesion and invasion on/into CECs.